Local Treatments of Oligometastatic and Oligoprogressive NSCLC Should Become the Standard of Care
J Thorac Oncol
.
2023 Aug;18(8):986-989.
doi: 10.1016/j.jtho.2023.05.003.
Author
Gregory M M Videtic
1
Affiliation
1
Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: videtig@ccf.org.
PMID:
37479329
DOI:
10.1016/j.jtho.2023.05.003
No abstract available
Publication types
Editorial
MeSH terms
Carcinoma, Non-Small-Cell Lung* / pathology
Carcinoma, Non-Small-Cell Lung* / therapy
Humans
Lung Neoplasms* / pathology
Lung Neoplasms* / therapy
Radiosurgery*
Standard of Care